Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Iron Mountain Inc (IRM) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance

Iron Mountain IncTrade
Recursion Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

Iron Mountain Inc vs Recursion Pharmaceuticals Inc — how do they compare? Iron Mountain Inc trades at $122.41 (market cap $36.44B), while Recursion Pharmaceuticals Inc trades at $3.35 (market cap $1.81B). The key difference: Iron Mountain Inc is far larger — about 20.1× Recursion Pharmaceuticals Inc's market cap, and Iron Mountain Inc pays a 2.82% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.

IRMRXRX
Market Cap
$36.44B$1.81B
Sector
Real EstateHealth
52-Week High
$133.06$6.79
52-Week Low
$78.86$2.84
Enterprise Value
$55.85B$1.33B
Dividend Yield
2.82%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Iron Mountain Inc

Iron Mountain Inc is a record management services provider. The firm is organized as a REIT. Most of its revenue comes from its storage business, with the rest coming from value-added services. The firm primarily caters to enterprise clients in developed markets. Its business segments include Global RIM Business

Read more on IRM

About Recursion Pharmaceuticals Inc

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.

Read more on RXRX